Our Services
Medical Information
Helpful Resources
Published on: 6/15/2026
Testosterone replacement therapy (TRT) can meaningfully improve energy, mood, sexual function, and bone density in men with true hypogonadism. However, TRT is only appropriate for men with persistent symptoms, consistently low morning testosterone levels, and after ruling out other causes—while weighing age, comorbidities, and fertility goals.
Endocrinologists stress thorough eligibility evaluation and transparent discussion of the four primary TRT risks: polycythemia, cardiovascular concerns, prostate effects, and fertility suppression. Assessment, monitoring protocols, and risk-mitigation strategies involve important nuances that can directly influence your treatment decisions.
Because low testosterone symptoms—fatigue, low libido, mood changes, weight gain—overlap with many other conditions, self-diagnosis is unreliable and delays effective care. The fastest, lowest-friction way to clarify what's actually driving your symptoms is to take a free, instant, online symptom check. In just minutes, you'll get a personalized assessment that helps you understand whether TRT evaluation is warranted, identify other potential causes, and pinpoint the right next step—whether that's lab testing, a specialist visit, or lifestyle adjustments. Don't guess when clarity is one click away.
Reviewed for medical accuracy: 06/15/2026
Testosterone replacement therapy (TRT) can offer significant benefits for men with clinically low testosterone. Improved energy, mood, sexual function and bone density are among its potential upsides. But TRT isn't for everyone. Proper evaluation and clear communication about risks are essential. Below, we cover who truly qualifies for TRT and outline the four main risks endocrinologists prioritize when counseling patients.
Endocrinology guidelines emphasize both symptoms and lab values when deciding on TRT. Not every man with a slightly low lab result needs treatment. Here's how specialists determine eligibility:
A trial of TRT begins with clear, persistent symptoms suggestive of low testosterone, such as:
Two separate morning blood tests (ideally between 7–10 am) should show total testosterone consistently below the lower limit (commonly < 300 ng/dL). In cases where symptoms strongly suggest low testosterone despite "borderline" total T, measuring free testosterone or bioavailable testosterone can help.
Before starting TRT, other medical issues must be ruled out:
Men planning to father children should discuss alternatives, as exogenous testosterone can suppress sperm production. Options like clomiphene citrate or hCG injections may preserve fertility while boosting testosterone.
If you're experiencing any of the symptoms listed above and want to better understand whether they could be related to Low Testosterone / Late Onset Hypogonadism, a free AI-powered symptom checker can help you prepare for a more informed conversation with your doctor.
Every medical treatment has potential downsides. Below are the four risks most often highlighted by endocrinologists when counseling men about TRT:
If you and your doctor decide TRT is appropriate, follow these best practices:
While TRT is generally safe under medical supervision, certain signs warrant prompt evaluation:
Speak to a doctor right away if you experience any of the above, as they could be life-threatening or serious.
Testosterone replacement therapy can markedly improve quality of life for men with true hypogonadism. However, candid discussion of eligibility and careful monitoring of the four primary risks—polycythemia, cardiovascular concerns, prostate effects and fertility suppression—is vital. Before scheduling an appointment with your healthcare provider, taking a few minutes to use a free symptom assessment tool for Low Testosterone / Late Onset Hypogonadism can help you articulate your concerns more clearly and make the most of your consultation time. Always partner with a qualified healthcare provider to determine whether TRT is right for you, and to ensure safe, effective treatment.
(References)
* Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018 Sep 1;103(9):3147-3150. doi: 10.1210/jc.2018-01292. Erratum in: J Clin Endocrinol Metab. 2019 Jan 1;104(1):257. PMID: 30006399.
* Yeap BB, et al. Testosterone therapy: A perspective on its risks and benefits. Clin Endocrinol (Oxf). 2019 Aug;91(2):167-177. doi: 10.1111/cen.13982. Epub 2019 May 30. PMID: 31050853.
* Rastrelli G, et al. Diagnosis and management of testosterone deficiency. J Endocrinol Invest. 2022 Mar;45(3):477-494. doi: 10.1007/s40618-021-01683-1. Epub 2021 Oct 23. PMID: 34687258; PMCID: PMC8538740.
* Chew K, et al. Testosterone Therapy and Cardiovascular Risk: A Meta-Analysis of Randomized Controlled Trials. Endocr Rev. 2020 Apr 1;41(2):292-313. doi: 10.1210/endrev/bnz002. PMID: 31925345.
* Diemer T, et al. Practical recommendations for the diagnosis and management of testosterone deficiency in men. World J Urol. 2021 Nov;39(11):4067-4081. doi: 10.1007/s00345-021-03688-6. Epub 2021 May 20. PMID: 34014902; PMCID: PMC8560946.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.